Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.53 USD | +2.65% | +4.62% | -33.36% |
Apr. 09 | Synaptogenix, Inc. acquired Unknown Stake in Psyga Bio Ltd from Cannasoul Analytics Ltd. | CI |
Apr. 03 | Synaptogenix Plans 1-for-25 Reverse Stock Split; Shares Fall | MT |
Chart calendar Synaptogenix, Inc.
Upcoming events on Synaptogenix, Inc.
No events available
Past events on Synaptogenix, Inc.
2023-12-20 11:00 am | Annual General Meeting |
2023-12-06 | IABS Forum |
2023-04-14 11:00 am | Extraordinary Shareholders Meeting |
2023-02-16 11:00 am | Extraordinary Shareholders Meeting |
2022-10-26 12:00 pm | ThinkEquity Conference |
2022-10-10 | Annual General Meeting |
2022-07-26 04:30 pm | Corporate Update Call |
2022-05-16 | Cell Symposium |
2022-03-29 02:00 pm | Hanson Wade Neurodegenerative Drug Development Summit |
2022-03-15 03:00 am | Alzheimer and Parkinson Diseases International Conference |
2021-09-29 02:40 pm | Benzinga Healthcare Small Cap Conference |
2021-09-13 07:00 am | H.C. Wainwright Global Investment Conference |
2021-07-26 04:15 pm | Alzheimers Association International Conference |
2021-04-28 12:40 pm | Sachs Neuroscience Innovation Forum |
2021-04-06 | Extraordinary Shareholders Meeting |
2021-03-14 10:00 am | Alzheimer and Parkinson Diseases International Conference |
2021-03-09 07:00 am | H.C. Wainwright Global Life Science Conference |
2021-02-17 11:30 am | MicroCap Rodeo Winter Wonderland Conference |
2020-12-15 04:15 pm | Business Update Call |
Annual results
Fiscal Period | December | 2021 | 2022 |
---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | 0,00 | -16,1 -13,4 -20.01% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -5,57 -13,3 57.95% |
Net income Million USD | Released Forecast Spread | -12,6 | -5,69 -13,3 57.07% |
EPS USD | Released Forecast Spread | -62,8 | -20,3 -47,3 57.14% |
Announcement Date | 29/03/22 | 21/03/23 |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | -3,28 -3,15 -4.21% | -3,80 -3,32 -14.52% | -3,17 -3,83 17.39% | -5,89 -3,20 -84.08% | -2,92 -3,91 25.29% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,28 -3,15 -4.06% | -3,75 -3,32 -13.18% | -3,03 -3,83 21.06% | 4,48 -3,20 240.12% | -1,71 -3,91 56.23% |
Net income Million USD | Released Forecast Spread | -3,28 -3,15 -4.06% | -3,75 -3,32 -13.18% | -3,03 -3,83 21.06% | 4,37 -3,20 236.49% | -1,98 -3,91 49.43% |
EPS USD | Released Forecast Spread | -11,8 -12,8 7.84% | -13,5 -12,0 -12.5% | -10,8 -13,8 21.82% | 15,8 -11,5 236.96% | -6,50 -14,0 53.57% |
Announcement Date | 13/05/22 | 05/08/22 | 10/11/22 | 21/03/23 | 15/05/23 |
Past sector events for Synaptogenix, Inc.
Today | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
Today | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
2024-04-26 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
2024-04-25 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
2024-04-25 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
2024-04-25 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
2024-04-25 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
2024-04-25 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
2024-04-25 07:00 am | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
2024-04-25 02:00 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SNPX Stock
- Calendar Synaptogenix, Inc.